Panlabs Biologics is a leading contract research organization with proven track record in microbial strain development, providing tailored-made solutions for global enterprises in fermentation related R&D services. Panlabs Biologics established the concept of dedicated custom research over 40 years ago, recognizing the trend toward outsourcing in the fermentation industry. Since then we have been assisting global enterprises to improve and advance their products.
Panlabs Biologics is assembled with a seasoned management team and experienced scientists with demonstrated capabilities in the R&D of industrial microorganisms and fermentation process. Each project is handled by a dedicate team of professionals to deliver streamline performance and ensure absolute confidentiality.
Our elaborate R&D services range from mutagenesis and rational screening of mutants (actinomycetes, algae, bacteria, filamentous fungi, and yeasts) to process development. We also own a microbial library collection of 20,000 strains, by which we offer biotransformation service and supply microbial NP library for new drug discovery. By optimizing synergies that exist between classical mutation and modern biotechnology toolboxes, we provide comprehensive solutions for numerous industries. In addition, we have been investing in advance high-throughput technologies to assist in mutant screening. This transition improves the chance of finding the high productivity strains and increases the process efficiency.